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 5 
Introduction 6 
Attenuation correction (AC) has become necessary in myocardial perfusion imaging 7 
(MPI) due to the likelihood of photon attenuation artefacts. In addition to a general 8 
reduction of photon counts in larger patients, localised photon attenuation artefacts 9 
typically caused by diaphragmatic attenuation in larger males and breast attenuation 10 
in larger females (1,2) can cause difficulties in interpretation. Misinterpretation could 11 
lead to unnecessary invasive intervention, such as coronary angiography. This type of 12 
error is clinically unacceptable, and a high-quality attenuation map is recommended 13 
to correct for these patient induced artefacts (3). For these reasons AC is 14 
recommended by the American Society of Nuclear Cardiology and Society of Nuclear 15 
Medicine for MPI studies (4). 16 
AC was initially performed using radionuclide based transmission images but has 17 
been superseded by an x-ray computed tomography (CT) based technique (5-7) 18 
In comparison to a radioactive line source, CT based AC has improved the quality of 19 
the attenuation map due to better spatial resolution, increased photon flux and no 20 
cross-talk from different radionuclide gamma ray energies. As a result MPI studies 21 
have seen improvements in diagnostic accuracy (8,9). 22 
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While the usefulness of CT based AC is clear there is controversy regarding what 23 
must be done about the incidentally produced low-resolution CT images that are the 24 
basis of AC. 25 
In the United Kingdom (UK), regulations dictate that a clinical evaluation and record 26 
must be made for every exposure (10). The implication here is that all image 27 
information should be reviewed, regardless of the reason for exposure (i.e. AC and 28 
not a diagnostic quality scan). However, the typically low quality of images produced 29 
for AC in single photon emission computed tomography/computed tomography 30 
(SPECT/CT) means that it is not clear whether this could be counterproductive. To 31 
further complicate this, the diagnostic quality of these images is also liable to 32 
significant variation due to the diversity of CT parameters used for an AC acquisition 33 
in different SPECT/CT systems. Despite variation in the acquisition, the reliability of 34 
attenuation maps provided by CT units has been found to be independent of both 35 
tube charge (mAs) (11) and tube rotation speed (12). Furthermore a static phantom 36 
study of the low-resolution CT images produced by a single SPECT/CT system for AC 37 
has reported that mAs had no impact on an observer’s ability to detect certain 38 
simulated lesions (13). 39 
Some retrospective clinical work has been done to evaluate the diagnostic suitability 40 
of these low-resolution images; Goetze et al (14) studied 200 consecutive patients 41 
undergoing attenuation corrected MPI using CT based AC in a single SPECT/CT 42 
system. The review of these coincidentally acquired low-resolution images revealed 43 
234 extracardiac abnormalities in 119 patients; 15 previously undiscovered incidental 44 
findings were categorized as having major significance, requiring either further 45 
testing or follow-up. An expert in CT and a resident in nuclear medicine with no 46 
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formal CT training completed this retrospective review and the results described the 47 
consensus opinion. Based on the consensus opinion the authors recommended 48 
routine assessment of these low-resolution images. However, no receiver operating 49 
characteristic (ROC) study was completed and their study was confined to a solitary 50 
SPECT/CT system while in practice there is considerable variation in acquisition 51 
parameters and other device characteristics between SPECT/CT systems in clinical 52 
use. The current study investigates the impact of the CT acquisition parameters used 53 
in five SPECT/CT systems in the UK.  54 
 55 
Materials and Methods 56 
Image Acquisition  57 
Since it would not be desirable from ethical and practical considerations to image 58 
enough patients in all five modalities to generate sufficient numbers of normal and 59 
abnormal cases for the observer study, a phantom study was indicated. Phantom 60 
simulation allows the production of reliable system-matched images without 61 
concerns over radiation dose.  62 
Spherical simulated lesions with diameters 3, 5, 8, 10 and 12mm, and densities -800, 63 
-630 and +100 Hounsfield Units (HU), for a total of 15 inserted lesions (some 64 
diameter-density combinations were repeated) which were manually inserted in 17 65 
trans-axial slices in an anthropomorphic chest phantom (Lungman N1 Multipurpose 66 
Chest Phantom, Kyoto Kagaku Company Ltd, Japan) representing a 70Kg male. The 67 
lesions were composed of urethane (-800 and -630HU) and a combination of 68 
polyurethane, hydroxyapatite and a urethane resin (+100HU). This resulted in 17 69 
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abnormal image slices, each containing 1-3 simulated pulmonary lesions, and 9 70 
normal slices, i.e., containing no lesions. The phantom was scanned on a dedicated 71 
diagnostic quality multi-detector CT (MDCT) scanner, not to be confused with CT 72 
units in the SPECT/CT systems, which were the subject of the comparison study. The 73 
MDCT images provided a lesion reference map that would act as the truth (gold-74 
standard) for the observer performance study. The high-resolution MDCT scan was 75 
repeated at the end of the SPECT/CT imaging, described next, to ensure that lesion 76 
positions had not changed. 77 
All images for the observer study were produced from a single CT acquisition of the 78 
phantom from each SPECT/CT system using site-specific CT acquisition protocols, 79 
Table 1, appropriate to a 70Kg male. The variation in CT acquisition parameters and 80 
estimated CT Dose Index (CTDI) listed in this Table is representative of general 81 
practice in the UK. The variation in slice thicknesses gave rise to a differing number of 82 
axial CT slices but each acquisition covered the full length of the phantom. Four 83 
SPECT/CT systems (labelled 1-4) used low-resolution CT systems from the same 84 
manufacturer, and the fifth (labelled 5) used a CT system capable of producing 85 
diagnostic quality images from a different manufacturer, which was used as a backup 86 
to the dedicated diagnostic CT system in that imaging facility.  87 
Figure 1, which shows two representative slices imaged using each SPECT/CT system, 88 
is arranged in 5 rows (labelled with numbers 1-5 corresponding to the 5 SPECT/CT 89 
systems) and two columns: the first labelled (a) corresponds to the abnormal slice 90 
(the arrow points to the location of the simulated lesion) and the second labelled (b) 91 
corresponds to the normal slice. Since the slices were not viewed in three-92 
dimensional volumetric mode, care had to be exercised in choosing the central 93 
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locations of the chosen slices so that sets of five “matched” slices, for example, those 94 
corresponding to each column in Figure 1, corresponded to the same physical region 95 
of the phantom. For normal slices this was achieved using anatomical landmarks 96 
(simulated major vessels and bony structures) visible on the high-resolution MDCT 97 
images. For abnormal slices this was achieved by selecting that slice that maximized 98 
the visual contrast of the contained lesion. 99 
 100 
Observer Performance Study 101 
Each CT acquisition produced 26 image slices for the observer performance study. 102 
Twenty-one professionals working in nuclear medicine (0-4 years CT experience, 103 
mean 1.2±1.2) each completed the study in a single session lasting approximately 90 104 
minutes. No time restriction was enforced. All selected Images, 26 from each of the 5 105 
SPECT/CT systems were pooled together and displayed in a different randomised 106 
order for each observer. The observer was unaware of the SPECT/CT system used to 107 
generate each image. Observers were informed they would be interpreting 17 108 
abnormal image slices, each containing 1-3 simulated pulmonary lesions, and 9 109 
normal slices, imaged in five modalities. They were required to localise all suspicious 110 
areas precisely using mouse clicks. Additionally, an individual confidence score 111 
rendered on a 10-point integer (1-10) rating scale, was required for each localisation 112 
(mark); this was implemented using a slider bar. Image evaluations were conducted 113 
using ROCView (15) (Bury St Edmunds, UK, www.rocview.net) on identical monitors 114 
(iiyama ProLite B2206WS 22 inch widescreen LCD, iiyama, Netherlands) (1680x1050 115 
pixels, 1.8 megapixel resolution), satisfying the standards set by The Royal College of 116 
Radiologists (16). Observations were completed in low ambient light environments. 117 
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Lesion visibility was maximised using a lung window setting (width 1500, level -500) 118 
which was held fixed for all observers. 119 
 120 
Each localisation (mark) was classified (scored) as lesion localisation (LL) or non-121 
lesion localisation (NL) using a 20-pixel radial diameter acceptance radius (AR) 122 
centred on each lesion. To test for effects of varying the acceptance radius, the data 123 
was also analysed using a 40-pixel acceptance radius. The analysis was repeated for 124 
two subgroupings of readers according to experience: 7 readers with no CT 125 
experience and 14 readers with CT experience.   126 
 127 
Statistical Analysis 128 
Multi-reader multi-case (MRMC) FROC ratings corresponding to 2730 (26 cases X 21 129 
observers X 5 SPECT/CT systems) individual slice observations were analysed using 130 
the jackknife alternative FROC (JAFROC) method (17) (JAFROC 4.2, 131 
www.devchakraborty.com/downloads). The outcome analysed was the unweighted 132 
JAFROC figure of merit (FOM), which is the empirical probability that a lesion is rated 133 
higher than any mark on a normal case (equal weighting was employed). The 134 
software also outputs the numbers of LL marks per slice and the average numbers of 135 
NL marks per normal slice, and the corresponding number per abnormal slice. 136 
The DLL module used for the significance testing was developed at the University of 137 
Iowa (18-24). The relevant statistics provided by the software are the F-statistic and 138 
p-value for testing the null hypothesis that all SPECT/CT systems have identical 139 
performance, the individual and observer averaged FOMs for each SPECT/CT system, 140 
the FOM differences between pairs of SPECT/CT systems, and 95% confidence 141 
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intervals for the FOMs and the paired differences. Since the results are specific to the 142 
particular phantom and slices used in the study, random-reader fixed-case results 143 
reported by the software are used. Analyses using the software were conducted 144 
separately for the four subsamples corresponding to the two values of acceptance 145 
radius (AR) and the two levels of CT experience. Since cases are treated as fixed, the 146 
observer FOMs, averaged across the five SPECT/CT systems are independent. 147 
Therefore we apply a two-independent-group t-test to the observer averaged FOMs 148 
(where CT experience is the grouping variable), providing a confidence interval. If the 149 
global test is significant, then we follow it by individual within-system confidence 150 
intervals. Type I error is controlled as follows. Consider the family of tests consisting 151 
of the five global tests: four tests for identical system performance and one test of 152 
identical experience performance. For this family the maximum type I error rate 153 
(probability that we will incorrectly conclude that there are any differences for any of 154 
the five groups) is limited to 0.05 by performing each of the five tests at the 155 
Bonferroni corrected level of alpha = 0.01. Follow-up 95% confidence intervals and 156 
corresponding hypotheses tests (alpha = 0.05) for pair-wise differences are reported 157 
only if the corresponding global test is significant; in this way, for a particular global 158 
test the overall type I error for follow-up tests (i.e., the probability that we will 159 
incorrectly observer any differences) is limited to .05 if there are no real differences. 160 
Thus, in order for a statistically significant difference to be declared, the p-value of 161 
the overall F-test had to be smaller than 0.01 and the 95% confidence interval for the 162 
paired difference between FOMs had to exclude zero. 163 
 164 
Plotting free-response data  165 
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Single rating per image ROC data is usefully visualized via the receiver operating 166 
characteristic (ROC) curve. Free-response data, consisting of mark-rating pairs, can be 167 
visualized in 3 ways. (1) The highest rating of all marks on a slice (or zero if the slice 168 
has no marks) is the highest rating inferred ROC rating of the slice; this can be used to 169 
construct inferred ROC curves (true positive fraction, TPF, vs. false positive fraction, 170 
FPF). (2) The FROC (free-response ROC) is the plot of lesion localization fraction (LLF = 171 
fraction of lesions correctly localized) vs. non-lesion localization fraction (NLF = 172 
number of non-lesions divided by the total number of slices). (3) The AFROC 173 
(alternative free-response ROC) is the plot of LLF vs. FPF: a linear interpolation from 174 
the uppermost operating point to (1,1) is included in the area under the AFROC, 175 
which is the JAFROC figure of merit. 176 
Empirical ROC/FROC/AFROC curves were produced for each SPECT/CT system. For 177 
the AFROC, linear interpolation was used to estimate the lesion localization fraction 178 
(LLF) for all observers at 200 abscissa values between operating points (0.005 179 




Table 2 summarizes the results of the four analyses conducted (for AR = 20, 40, CT 184 
experienced and no CT experience): it lists the F statistic, and in parenthesis the 185 
numerator and denominator degrees of freedom, the P-value, the average number of 186 
NL marks per normal slice, the corresponding number per abnormal slice, and the 187 
average number of LL marks per abnormal slice. For 20-pixel acceptance radius and 188 
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all 21 readers, Figure 2a displays the JAFROC FOMs and 95% confidence intervals for 189 
the five SPECT/CT systems; the FOM values were 0.602, 0.639, 0.372, 0.475 and 190 
0.719 respectively. Figure 2 (a) shows that system 3 had the lowest FOM, while 191 
system 5 had the highest, 1 and 2 were similar, and slightly below 5, while 4 was 192 
intermediate between 3 and 5. Differences between pairs of SPECT/CT system and 193 
corresponding confidence intervals are shown in Figure 2b. A statistically significant 194 
difference in FOMs (confidence interval not including zero) was found between all 195 
but one pair of SPECT/CT systems (the 1-2 pairing difference was not significant – 196 
these systems only differed in mAs values, Table 1). SPECT/CT system 5 was 197 
significantly superior to all other SPECT/CT systems. The significance of differences in 198 
SPECT/CT system pairings were unchanged for the other three analyses (AR = 40, CT 199 
experienced, no CT experience) with one difference: the SPECT systems 1 vs. 2 200 
difference became significant (with 2 superior) for AR = 20 for the CT experienced 201 
readers – i.e., the higher mAs system was significantly superior for the experienced 202 
readers provided the tighter acceptance radius criterion was adopted.  203 
Figure 3 shows reader averaged inferred ROC, FROC and AFROC curves for AR = 20 204 
and all 21 readers. The AFROC/FROC curves for AR = 40 are visually identical to those 205 
shown in Figure 3; the small increments in FOM are not visually apparent. Since 206 
localization specific scoring is not performed in ROC analysis, the ROC curves are 207 
independent of AR. Figure 4 compares the reader averaged FOMs of the CT 208 
experienced, n = 14; and no CT experience, n = 7. Despite a trend towards higher 209 
FOMs for the experienced group (modality averaged value = 0.596 for experienced 210 
group vs. 0.492 for the inexperienced group), the Welch’s 2-sample t-test of the 211 
modality-averaged JAFROC FOMs between the two experience based reader groups 212 
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revealed no significant difference in lesion detection performance on the basis of CT 213 
experience (p = 0.0539, subgroup difference 0.105 (95% CI -0.002, 0.211). 214 
 215 
Discussion 216 
This study evaluated lesion detectability in the low-resolution CT images acquired for 217 
attenuation correction as part of the SPECT/CT myocardial perfusion imaging 218 
technique. The diagnostic value of these images has been in question, but the work 219 
of Goetze et al (14) has suggested that there is value in reporting interpretations 220 
from these images. Legislative pressures in the UK also require a formal record of 221 
each exposure to be created. 222 
The statistically significant differences observed in this study, which were especially 223 
large for SPECT/CT system 5 compared to the others, suggest that there may be some 224 
clinical implications of the differences in image acquisition parameters between 225 
clinical centres. We believe this is the first work to assess the influence of the CT 226 
protocol on the diagnostic potential of the attenuation corrected images in patients 227 
undergoing myocardial perfusion imaging. 228 
 229 
Previous work (13) with 20 readers on the detection of simulated lesions on CT 230 
images acquired for AC using a free-response study was unable to demonstrate 231 
statistically different performance when changing mAs over the range 15.8 to 39.5. 232 
The current work was likewise unable to detect a mAs effect if all observers were 233 
included (n=21; AR = 20 and 40 pixels). However, when we restricted to CT 234 
experienced observers (n=14) and a tight acceptance radius (AR = 20 pixels) the mAs 235 
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effect (SPECT systems 1 vs. 2) became significant. The ability to demonstrated 236 
significance is likely due to two factors: (i) using the more lax acceptance radius (AR = 237 
40) is expected to confuse perceptual NLs (incorrect decisions) as LLs (scored correct 238 
decisions) (25), and (ii) using experienced observers is expected to reduce inter-239 
reader variability. Both of these effects are expected to increase statistical power. 240 
 241 
From examination of Figure 2 (b), and focusing on the differences with the largest 242 
magnitudes, it appears that the axial (z-axis) resolution (i.e., reconstructed slice 243 
thickness) and matrix size appear to be the main factor in determining lesion 244 
detection performance, with smaller slice thickness and larger matrix sizes 245 
contributing to higher performance. The comparatively higher performance of 246 
system 2 (6.1 mm thick slices) relative to system 3 (10mm thick slice) is consistent 247 
with the slice thickness effect, as is the superiority of system 5 (5 mm thick slices) to 248 
all other systems. The superiority of system 4 to 3 is attributable to the larger matrix 249 
size of the former. SPECT/CT system 5, the only system with diagnostic capability, 250 
showed the highest observer performance, being statistically better than all other 251 
systems. System 5 uses a lower kilovolt potential and a smaller pixel size to offer 252 
improved image contrast and spatial resolution respectively. The reconstructed slice 253 
thickness is also smaller, thus providing improved axial resolution. 254 
Initially we had concerns that a larger reconstructed slice thickness may favour lesion 255 
detection, when using single axial images vs. three-dimensional display, due to less 256 
noise being present in the image. However lesion detection improved as the 257 
reconstructed slice thickness decreased, suggesting that the partial volume effect has 258 
a greater impact on lesion detection than image noise. 259 
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While lesion detection performance for the CT experienced group was somewhat 260 
higher than for the inexperienced group, Figure 4, the difference was not statistically 261 
significant. However, this subgroup analysis may have relevance to the nuclear 262 
medicine community, where CT interpretation skills can vary broadly due to the 263 
training pathway of those reporting myocardial perfusion imaging studies (i.e. 264 
radiologist vs. nuclear medicine physician). It has been suggested that further 265 
training might be required for clinicians with less experience in CT to recognise extra-266 
cardiac findings and establish the need for follow-up (26). More specifically, it has 267 
been recommended (27) that nuclear medicine physicians without CT training should 268 
report only the functional data (SPECT) with radiologists involved to report the 269 
anatomical data (CT), therefore providing a collaborative report. 270 
 271 
This laboratory study reflects the variation in CT protocols used for AC in the UK. 272 
However, limitations are evident in this type of phantom study. Respiratory motion 273 
was not simulated and this is likely to have effect in a patient population. In this 274 
study, tube rotation times ranged from 1.5 seconds (treatment 5) to 23.1 and 30 275 
seconds (treatments 1-4) which could allow 4-5 normal breathing cycles to occur, 276 
thus allowing greater potential for respiratory motion artefacts (28). Respiratory 277 
motion artefacts are evident with slow and fast tube rotation speeds, with greater 278 





Protocol variations in operation for CT based AC have a significant impact on lesion 282 
detection performance. The results imply that z-axis resolution and matrix size had 283 
the greatest impact on lesion detection, with a weaker but detectable dependence 284 
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Figure Captions 302 
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Figure 1: An abnormal slice (left column, labelled a) containing a 12mm and -630 HU 303 
simulated lesion (arrowed), and a normal slice (right column, labelled b) for each of 304 
the five SPECT/CT systems (numbered 1 - 5) used in this study. 305 
 306 
Figure 2a: JAFROC figures-of-merit (FOM) and 95% confidence intervals for the 5 307 
SPECT/CT systems (AR = 20). 308 
 309 
Figure 2b: FOM difference (AR = 20) for all SPECT/CT system pairings (labelled on the 310 
x-axis; e.g., 1 – 2 means FOM for system 1 minus that for system 2) and 95% 311 
confidence intervals. Confidence intervals that do not include zero demonstrate a 312 
significant difference between the corresponding treatments. 313 
 314 
Figure 3: Empirical reader averaged ROC, FROC and AFROC curves for all SPECT/CT 315 
systems using an acceptance radius of 20-pixels. 316 
 317 
Figure 4: Illustrating the effect of CT experience. Shown are reader averaged JAFROC 318 
figures-of-merit and 95% confidence intervals. CT experience: 14 readers; no-CT 319 
experience: 7 readers. 320 
 321 
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